Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current

News

Organon Q2 Adj. EPS $1.00 Beats $0.94 Estimate, Sales $1.594B Beat $1.552B Estimate

Author: Benzinga Newsdesk | August 05, 2025 07:30am
Organon (NYSE:OGN) reported quarterly earnings of $1.00 per share which beat the analyst consensus estimate of $0.94 by 6.84 percent. This is a 10.71 percent decrease over earnings of $1.12 per share from the same period last year. The company reported quarterly sales of $1.594 billion which beat the analyst consensus estimate of $1.552 billion by 2.73 percent. This is a 0.81 percent decrease over sales of $1.607 billion the same period last year.

Posted In: OGN

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist